Antiscience and ethical concerns associated with advocacy of Lyme disease.

作者: Paul G Auwaerter , Johan S Bakken , Raymond J Dattwyler , J Stephen Dumler , John J Halperin

DOI: 10.1016/S1473-3099(11)70034-2

关键词:

摘要: Advocacy for Lyme disease has become an increasingly important part of antiscience movement that denies both the viral cause AIDS and benefits vaccines supports unproven (sometimes dangerous) alternative medical treatments. Some activists portray disease, a geographically limited tick-borne infection, as is insidious, ubiquitous, difficult to diagnose, almost incurable; they also propose causes mainly non-specific symptoms can be treated only with long-term antibiotics other unorthodox unvalidated Similar groups, these advocates have created pseudoscientific selection practitioners, research, publications coordinated public protests, accused opponents corruption conspiracy, spurred legislative efforts subvert evidence-based medicine peer-reviewed science. The relations actions some activists, commercial bodies involved in advocacy pose threat health.

参考文章(41)
, Evidence-based guidelines for the management of Lyme disease Expert Review of Anti-infective Therapy. ,vol. 2, pp. S1- S13 ,(2004) , 10.1586/14789072.2.1.S1
Raymond J. Dattwyler, Gary P. Wormser, Thomas J. Rush, Michael F. Finkel, Robert T. Schoen, Edgar Grunwaldt, Michael Franklin, Eileen Hilton, Gary L. Bryant, William A. Agger, Dionigi Maladorno, A comparison of two treatment regimens of ceftriaxone in late Lyme disease. Wiener Klinische Wochenschrift. ,vol. 117, pp. 393- 397 ,(2005) , 10.1007/S00508-005-0361-8
Julian Upton, Under our skin Lancet Infectious Diseases. ,vol. 8, pp. 358- ,(2008) , 10.1016/S1473-3099(08)70125-7
David C. Zoschke, Lymphoproliferative Responses to Borrelia burgdorferi in Lyme Disease Annals of Internal Medicine. ,vol. 114, pp. 285- 289 ,(1991) , 10.7326/0003-4819-114-4-285
J. J. Halperin, Prolonged Lyme disease treatment : Enough is enough Neurology. ,vol. 70, pp. 986- 987 ,(2008) , 10.1212/01.WNL.0000291407.40667.69
J. Oksi, J. Nikoskelainen, H. Hiekkanen, A. Lauhio, M. Peltomaa, A. Pitkäranta, D. Nyman, H. Granlund, S.-A. Carlsson, I. Seppälä, V. Valtonen, M. Viljanen, Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study European Journal of Clinical Microbiology & Infectious Diseases. ,vol. 26, pp. 571- 581 ,(2007) , 10.1007/S10096-007-0340-2
Edward McSweegan, Lyme Disease and the Politics of Public Advocacy Clinical Infectious Diseases. ,vol. 47, pp. 1609- 1610 ,(2008) , 10.1086/595684
Gary P. Wormser, Roshan Ramanathan, John Nowakowski, Donna McKenna, Diane Holmgren, Paul Visintainer, Rhea Dornbush, Brij Singh, Robert B. Nadelman, Duration of Antibiotic Therapy for Early Lyme Disease: A Randomized, Double-Blind, Placebo-Controlled Trial Annals of Internal Medicine. ,vol. 138, pp. 697- 704 ,(2003) , 10.7326/0003-4819-138-9-200305060-00005